News | July 03, 2012

New Echocardiographic Methods Find Cardiac Dysfunction in One of Four Morbidly Obese Patients

July 3, 2012 — Researchers have announced the results of a study that highlights new echocardiographic methods that can detect latent systolic function in obese patients.

“Obesity is a major public health problem in the United States, and increases the risk of various cardiovascular diseases. Our study evaluated both the relaxation and contraction phase of the heart’s function in morbidly obese patients referred for preoperative evaluation prior to bariatric surgery. We found that two out of five morbidly obese patients have abnormalities in the relaxation phase of the heart (stiff hearts). Furthermore, one in five of those with relaxation abnormalities also have early evidence of contraction abnormalities,” explained Farooq A. Chaudhry, MD, Associate Chief of Cardiology, Director of Echocardiography and Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons and St. Luke's Roosevelt Hospital Center, New York, NY, senior author of the study.

The study, led by primary investigator Harikrishna Makani, also from Columbia University College of Physicians and Surgeons and St. Luke's Roosevelt Hospital Center, included 340 patients who were referred for stress echocardiography for pre-operative evaluation prior to bariatric surgery. The authors utilized echocardiographic blood and tissue Doppler imaging parameters specifically assessing the relaxation and contraction phase of the heart. They found that abnormalities in the relaxation phase in this patient population are frequently accompanied by early contraction abnormalities as well.

A poster based on the results will be displayed on Monday, July 2, in the poster and exhibit hall at the American Society of Echocardiography (ASE) 23rd Annual Scientific Sessions at the Gaylord National, National Harbor, Md. Researchers will be available in the Hall from 12:15 p.m. to 1:45 p.m.

For more information: www.asecho.org

Related Content

Lexington Begins HeartSentry Clinical Trial
News | Clinical Study | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Clinical Study | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Clinical Study | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Clinical Study | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Clinical Study | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init